Novo Nordisk, underway with key launches, reveals $2.58B manufacturing investment | Fierce Pharma
Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds | Fierce Pharma
Novo Nordisk Foundation - Wikipedia
FDA approves Novo Nordisk's weight-loss drug Wegovy for teens - NJBIZ
Novo Nordisk (B): The Prandin/Novonorm Global Product Launch - The Case Centre
Novo Nordisk CEO: Very upbeat on outlook for 2022
Novo Nordisk to Sell Discount Insulin After Criticism Over Price - Bloomberg
Lene B. Oddershede to head Novo Nordisk Foundation's grants for research in the natural and technical sciences - Novo Nordisk Fonden
From R&D to M&A: Novo Nordisk to Acquire Dicerna for $3.3B
Novo Nordisk pauses trials in haemophilia A and B - Nordic Life Science – the leading Nordic life science news service
Statement from Novo Nordisk on Rebinyn and COVID-19 — The Coalition for Hemophilia B
Drugmaker Novo Nordisk profits jump in diabetes scourge
With new FDA submission, Novo Nordisk aims to trumpet Tresiba's hypoglycemia edge | Fierce Pharma
MEDIA B-ROLL : Novo Nordisk insulin manufacturing facility, Claros, Brazil
ar_001.jpg
Abbott and Novo Nordisk to offer integrated solution for diabetes
Novo Nordisk to buy sickle cell disease biotech Forma Therapeutics in $1.1B deal - MedCity News
MEDIA B-ROLL : Novo Nordisk site in Montes Clares, Brazil
Novo-Nordisk B dividend yield
Novo Nordisk (NVO) Stock: Attractive Market But Likely No Margin Of Safety | Seeking Alpha
Novo Nordisk (NOVO-B) hit by drop in insulin sales in China
